Document is current
Any future updates will be listed below
-
Authors
Wang, Ivan E. https://orcid.org/0000-0002-1318-9522
Morrissette, Luke J.
Wong, Ka Kit
Brooks, Allen F.
Dakanali, Marianna
Scott, Peter J. H. https://orcid.org/0000-0002-6505-0450
-
Funding
Funding for this research was provided by:
University of Michigan (Department of Radiology)
University of Michigan (Support for Outstanding Academic Research)
University of Michigan (SOAR)
- License Information
-
More Information
Article History
Received: 31 October 2024
Accepted: 26 November 2024
First Online: 18 December 2024
Declarations
:
: Not applicable as this article does not contain any original research studies with human or animal subjects performed by any of the authors.
: Not applicable as this article does not contain any original research studies with human or animal subjects performed by any of the authors.
: Provided in the Supplementary Information is a list of Formulation, components of the Locametz and Illuccix kits (Table S1), as well as a list of disposable and non-disposable items used in both the production of Locametz (Table S2) and Illuccix (Table S3). Additionally, required materials for quality control is also provided (Table S4). Provided in an Excel sheet (Appendix A) is the raw data for all 437 PSMA-11 production batches reported and analyzed in this article. The preparer’s names have been replaced with generic names (Person A, Person B, etc.) in the Excel sheet, but reflect the actual radiochemists’s role for each batch.
: IEW, LJM, KKW, AFB and MD disclose no competing interests. PJHS holds equity in Novartis and Telix Pharmaceuticals. Given his role as Associate Editor, Peter J. H. Scott had no involvement in the peer-review of this article and has no access to information regarding its peer-review.
